Neuroblastoma is a devastating childhood cancer with low survival rates, especially after relapse. We fund pioneering research, support families through treatment, and campaign for equal access to life-saving care – giving every child the best chance to survive.
Categories
Beneficiaries
Neuroblastoma is one of the most aggressive childhood cancers, mainly affecting children under five. Only around 50% of children with high-risk disease survive. After relapse, this drops to 10%. Treatment is intensive and toxic, access to new therapies is unequal, and research remains chronically underfunded, leaving families facing devastating emotional and financial strain.
We take a three-pillar approach: providing expert family support through diagnosis, treatment and bereavement; funding and accelerating clinical research into better, less toxic therapies; and advocating for equal access to innovative treatments and trials. Combining lived experience with scientific expertise, we are striving towards a future where no child dies of the childhood cancer neuroblastoma or suffers due to the treatment they receive.